BofA Securities Downgrades Zymergen Inc (ZY) to Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts ZY Hot Sheet
Price: $2.43 --0%
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 92
Join SI Premium – FREE
BofA Securities analyst Derik de Bruin downgraded Zymergen Inc (NASDAQ: ZY) from Buy to Underperform with a price target of $7.00 (from $43.00).
For an analyst ratings summary and ratings history on Zymergen Inc click here. For more ratings news on Zymergen Inc click here.
Shares of Zymergen Inc closed at $34.83 yesterday.
You May Also Be Interested In
- Axis Capital Limited Upgrades Ashok Leyland Ltd. (AL:IN) to Buy (1)
- SSAB AB (SSABB:SS) (SSAAY) PT Raised to SEK98 at JPMorgan
- Outokumpu OYJ (OUT1V:FH) (OUTFF) PT Lowered to EUR6.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
